N. Devlin

发表

EQ-5D and the EuroQol Group: Past, Present and Future

N. Devlin, R. Brooks, 2017, Applied Health Economics and Health Policy.

Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?

M. Herdman, N. Devlin, Yan Feng, 2015, Health and Quality of Life Outcomes.

The Influence of Cost-Effectiveness and Other Factors on NICE Decisions

N. Devlin, N. Rice, D. Parkin, 2010, Health economics.

Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force.

Maarten J. IJzerman, John B. Watkins, R. Baltussen, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Equity and efficiency in public health: The contribution of health economics

S. Morris, N. Devlin, D. Parkin, 2010 .

Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data.

David Parkin, John Browne, Nancy J Devlin, 2010, Health economics.

Using the EQ-5D as a performance measurement tool in the NHS

David Parkin, Nancy Devlin, John Browne, 2009 .

Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bias Inference?

Nigel Rice, David Parkin, Nancy Devlin, 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

New Methods for Analysing the Distribution of EQ-5D Observations

David Parkin, Yan Feng, Nancy Devlin, 2018 .

Continuity through change: the rhetoric and reality of health reform in New Zealand.

N. Mays, N. Devlin, T. Ashton, 2005, Social science & medicine.

Methods for Analysing and Reporting EQ-5D Data

N. Devlin, D. Parkin, B. Janssen, 2020 .

Analysis of EQ-5D Values

N. Devlin, D. Parkin, B. Janssen, 2020, Methods for Analysing and Reporting EQ-5D Data.

Valuing health‐related quality of life: An EQ‐5D‐5L value set for England

Brendan Mulhern, Yan Feng, Ben van Hout, 2017, Health economics.

Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in ireland.

N. Devlin, K. Shah, C. O’Neill, 2020, Health policy.

3L, 5L, What the L? A NICE Conundrum

J. Brazier, A. Pickard, N. Devlin, 2018, PharmacoEconomics.

Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets

M. Herdman, N. Devlin, B. van Hout, 2018, PharmacoEconomics.

Response to: Quality review of a proposed EQ-5D-5L value set for England

N. Devlin, B. Mulhern, K. Shah, 2018 .

Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial

M. Herdman, N. Devlin, M. Pavesi, 2017, The Patient - Patient-Centered Outcomes Research.

Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment

N. Devlin, B. Mulhern, K. Shah, 2018, The European Journal of Health Economics.

An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D

C. Cleeland, S. Ikeda, M. Herdman, 2017, Quality of Life Research.

Do Nice Decisions Affect Decisions in Other Countries?

N. Devlin, K. Hernandez-Villafuerte, M. Garau, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Preparatory study for the revaluation of the EQ-5D tariff: methodology report.

J. Cairns, J. Brazier, A. Tsuchiya, 2014, Health technology assessment.

Binary Choice Health State Valuation and Mode of Administration: Head-to-Head Comparison of Online and CAPI

Aki Tsuchiya, Brendan Mulhern, John Brazier, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand.

N. Devlin, N. Devlin, K L Szeto, 1996, Health policy.

The costs of mammography screening in New Zealand: evidence from the pilot programmes.

N. Devlin, A. Menon, A. Richardson, 1994, The New Zealand medical journal.

Longitudinal study of patients’ health-related quality of life using EQ-5D-3L in 11 Swedish National Quality Registers

N. Devlin, D. Parkin, O. Rolfson, 2022, BMJ Open.

An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate Health State Values in the United Arab Emirates.

Iain Blair, Marina-Selini Katsaiti, Nancy J Devlin, 2015, Value in health regional issues.

Comprar EQ-5D Value Sets: Inventory, Comparative Review and User Guide | Szende, Agota | 9781402055102 | Springer

N. Devlin, M. Oppe, A. Szende, 2007 .

Logical inconsistencies in survey respondents' health state valuations -- a methodological challenge for estimating social tariffs.

Paul Kind, Paul Hansen, Alan Williams, 2003, Health economics.

Time to Tweak the TTO: But How?

N. Devlin, M. Versteegh, E. Stolk, 2012 .

Analysis of EQ VAS Data

David Parkin, Nancy Devlin, Bas Janssen, 2020 .

The development of new research methods for the valuation of EQ-5D-5L

N. Devlin, P. Krabbe, 2013, The European Journal of Health Economics.

Time to tweak the TTO: results from a comparison of alternative specifications of the TTO

N. Devlin, M. Versteegh, E. Stolk, 2013, The European Journal of Health Economics.

Age and Utilities: Issues for HTA

M. Herdman, N. Devlin, K. Shah, 2017 .

How are Child-Specific Utility Instruments Used in Decision Making in Australia? A Review of Pharmaceutical Benefits Advisory Committee Public Summary Documents

R. Viney, P. Cronin, N. Devlin, 2021, PharmacoEconomics.

Preference Elicitation Techniques Used in Valuing Children’s Health-Related Quality-of-Life: A Systematic Review

D. Street, R. Norman, R. Viney, 2022, PharmacoEconomics.

What Determines the Shape of an EQ-5D Index Distribution?

N. Devlin, D. Parkin, Yan Feng, 2014 .

Understanding the effects on HR-QoL of treatment for overactive bladder: a detailed analysis of EQ-5D clinical trial data for mirabegron

M. Herdman, N. Devlin, M. Pavesi, 2013, Journal of medical economics.

Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets

M. Herdman, N. Devlin, B. van Hout, 2018, PharmacoEconomics.

Searching for Cost-Effectiveness Thresholds in NHS Scotland

N. Devlin, J. Sussex, A. Walker, 2013 .

The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.

P. Scuffham, N. Devlin, N. Devlin, 1999, Social science & medicine.

Analysing hospital variation in health outcome at the level of EQ-5D dimensions

A. Street, N. Devlin, N. Gutacker, 2012 .

Preference Elicitation Techniques Used in Valuing Children’s Health-Related Quality-of-Life: A Systematic Review

D. Street, R. Norman, R. Viney, 2022, PharmacoEconomics.

The social costs of alcohol abuse in New Zealand.

P. Scuffham, N. Devlin, L. Bunt, 1997, Addiction.

A Study of the Relationship Between Health and Subjective Well-being in Parkinson ’ s Disease Patients July 2013

N. Devlin, P. Cubi-Molla, J. Vries, 2013 .

Valuing Child Health Isn't Child's Play.

N. Devlin, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England

N. Devlin, D. Parkin, K. Hernandez-Villafuerte, 2019 .

Public Preferences for Health Gains and Cures: A Discrete Choice Experiment

N. Devlin, K. Shah, G. Hampson, 2019 .

The Economics of a ‘Liberated’ NHS

N. Devlin, 2012, PharmacoEconomics.

Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.

David Parkin, Nancy Devlin, N. Devlin, 2004, Health economics.

An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions

N. Devlin, P. O’Neill, 2012, PharmacoEconomics.

Value Insider Season 1 Episode 2: How to Measure Quality of Life and Utility? (QoL) [Podcast]

N. Devlin, Michael Chambers, Elisabeth Sophia Hartgers-Gubbels, 2022, International journal of general medicine.

A "new and improved" EQ-5D valuation questionnaire? Results from a pilot study.

P. Hansen, N. Devlin, P. Herbison, 2005, The European journal of health economics : HEPAC : health economics in prevention and care.

Funding fertility: Issues in the allocation and distribution of resources to assisted reproduction technologies

N. Devlin, D. Parkin, 2003, Human fertility.

Multinational Evidence of the Applicability and Robustness of Discrete Choice Modeling for Deriving EQ-5D-5L Health-State Values

Mark Oppe, Elly A. Stolk, Paul F. M. Krabbe, 2014, Medical care.

DO ADULT AND ADOLESCENT PREFERENCES DIFFER?

N. Devlin, O. Rivero-Arias, K. Shah, 2019 .

Using health status to measure NHS performance: casting light in dark places

N. Devlin, D. Parkin, 2011, BMJ quality & safety.

Does the value of quality of life depend on duration

A. Tsuchiya, N. Devlin, K. Buckingham, 2009 .

EQ-5D Value Sets

Mark Oppe, Nancy Devlin, N. Devlin, 2007 .

EQ-5D value sets : inventory, comparative review, and user guide

Mark Oppe, Nancy Devlin, Agota Szende, 2007 .

Euthanasia, religiosity and the valuation of health states: results from an Irish EQ5D5L valuation study and their implications for anchor values

N. Devlin, K. Shah, C. O’Neill, 2018, Health and Quality of Life Outcomes.

Development of the EQ-5D-Y: a child-friendly version of the EQ-5D

Michael Herdman, Paul Kind, Xavier Badia, 2010, Quality of Life Research.

A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.

Mark Oppe, Ben van Hout, Nancy J Devlin, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.

Zoltán Kaló, Stuart Peacock, Maarten J. IJzerman, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Assessing the performance of the EQ-VAS in the NHS PROMs programme

David Parkin, Yan Feng, N. Devlin, 2012, Quality of Life Research.

The Effect of Perceived Risks on the Demand for Vaccination: Results from a Discrete Choice Experiment

W. Edmunds, N. Devlin, D. Parkin, 2013, PloS one.

An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values

N. Devlin, K. Shah, S. Kreimeier, 2020, The European Journal of Health Economics.

International Valuation Protocol for the EQ-5D-Y-3L

Mark Oppe, Elly Stolk, Koonal Shah, 2020, PharmacoEconomics.

A new tool for creating personal and social EQ-5D-5L value sets, including valuing 'dead'.

Paul Hansen, Nancy Devlin, Trudy Sullivan, 2019, Social science & medicine.

A new method for valuing health: directly eliciting personal utility functions

Brendan J Mulhern, Ben van Hout, Nancy J Devlin, 2018, The European Journal of Health Economics.

Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale

A. Pickard, N. Devlin, P. Krabbe, 2016, The European Journal of Health Economics.

Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review.

M. Herdman, N. Devlin, S. Carroll, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.

Michael Koller, Corneel Coens, Andrew Bottomley, 2020, The Lancet. Oncology.

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.

L. Collette, M. Piccart, M. Taphoorn, 2016, The Lancet. Oncology.

The effects of denturism: New Zealand dentists' response to competition.

N. Devlin, 1994, American journal of public health.

Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up.

S. Brooker, N. Devlin, N. Kabatereine, 2007, Health policy and planning.

Sugammadex, neostigmine and postoperative pulmonary complications: an international randomised feasibility and pilot trial

K. Leslie, N. Devlin, M. Chan, 2021, Pilot and Feasibility Studies.

Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.

L. Collette, M. Piccart, J. Reijneveld, 2018, The Lancet. Oncology.

M. Herdman, B. Tombal, N. Devlin, 2017, Health and Quality of Life Outcomes.

A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications

Nancy Devlin, N. Devlin, G. Marsden, 2016 .

Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?

Donna Rowen, Julie Ratcliffe, Oliver Rivero-Arias, 2020, PharmacoEconomics.

Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.

Mark Oppe, Michael Herdman, Elly Stolk, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study

G. Bonsel, P. Kind, X. Badia, 2010, Quality of Life Research.

New methods for modelling EQ‐5D‐5L value sets: An application to English data

Brendan Mulhern, Yan Feng, Ben van Hout, 2017, Health economics.

International guidelines for self-report and proxy completion of paediatric health-related quality of life measures: a protocol for a systematic review

J. Ratcliffe, N. Devlin, Christine Mpundu-Kaambwa, 2021, BMJ Open.

Protocols for TTO valuations of health states worse than dead: A literature review and framework for systematic analysis

A. Tsuchiya, N. Devlin, K. Buckingham, 2008 .

A theoretical framework for TTO valuations of health.

N. Devlin, K. Buckingham, 2006, Health economics.

Is there a case for using visual analogue scale valuations in cost-utility analysis?

David Parkin, Nancy Devlin, N. Devlin, 2006, Health economics.

Assessing Patient-Reported Outcomes in Pediatric Populations With Vaccine-Preventable Infectious Diseases: A Systematic Review of the Literature (the PROCHID Study).

M. Herdman, N. Devlin, S. Carroll, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE)

David Feeny, Rosalie Viney, Paul F. M. Krabbe, 2015, PharmacoEconomics.

QALYs as a measure of value in cancer

N. Devlin, P. Lorgelly, 2017 .

A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact?

Nancy Devlin, N. Devlin, G. Marsden, 2017, Applied Health Economics and Health Policy.

Economic Analysis in Health Care

David Parkin, Stephen Morris, Nancy Devlin, 2007 .

A comparison of alternative variants of the lead and lag time TTO.

Aki Tsuchiya, Koonal Shah, Ben van Hout, 2013, Health economics.

EQ-5 D and the EuroQol Group : Past , Present and Future

N. Devlin, R. Brooks, Nancy J. Devlin, 2017 .

The impact of price transparency on consumers and providers: A scoping review.

A. Scott, A. Zhang, N. Devlin, 2020, Health policy.

Understanding individuals’ decisions about vaccination: a comparison between Expected Utility and Regret Theory models

W. Edmunds, N. Devlin, D. Parkin, 2005 .

Putting patient-reported outcomes on the ‘Big Data Road Map’

N. Devlin, D. Kyte, M. Calvert, 2015, Journal of the Royal Society of Medicine.

The structure of costs and production in New Zealand public hospitals: and application of the transcendental logarithmic vaiable cost funcation

P. Scuffham, N. Devlin, M. Jaforullah, 1996 .

A Study of the Relationship between Health and Subjective Well-Being in Parkinson's Disease Patients

N. Devlin, P. Cubi-Molla, J. de Vries, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

An Introduction to EQ-5D Instruments and Their Applications

David Parkin, Nancy Devlin, Bas Janssen, 2020, Methods for Analysing and Reporting EQ-5D Data.

The effect of religion on the perception of health states among adults in the United Arab Emirates: a qualitative study

N. Devlin, K. Shah, E. Papadimitropoulos, 2017, BMJ Open.

Association between market concentration of hospitals and patient health gain following hip replacement surgery

C. Propper, N. Devlin, A. Charlesworth, 2015, Journal of health services research & policy.

Variations in outcome and costs among NHS providers for common surgical procedures : econometric analyses of routinely collected data

A. Street, N. Devlin, N. Gutacker, 2014 .

Hospital Variation in Patient-Reported Outcomes at the Level of EQ-5D Dimensions

Andrew Street, Nils Gutacker, Chris Bojke, 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

A Comparison of PROPr and EQ-5D-5L Value Sets

R. Norman, R. Viney, J. Hanmer, 2021, PharmacoEconomics.

Evidence on the relationship between PROMIS-29 and EQ-5D: a literature review

R. Norman, R. Viney, J. Hanmer, 2021, Quality of Life Research.

What Determines the Shape of an EQ-5D Index Distribution?

David Parkin, Yan Feng, Nancy Devlin, 2014, Medical decision making : an international journal of the Society for Medical Decision Making.

Health care spending and economic output: Granger causality

P. Hansen, N. Devlin, 2001 .

Comparison of the underlying constructs of the EQ-5D and Oxford Hip Score: implications for mapping.

Mark Oppe, Nick Black, Nancy Devlin, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Developing a health, social care and carer-related quality of life instrument to measure QALYs

J. Connell, J. Brazier, N. Devlin, 2018 .

The development of new research methods for the valuation of EQ-5D-5L

Paul F. M. Krabbe, N. Devlin, P. Krabbe, 2013, The European Journal of Health Economics.

Proceedings of Patient Reported Outcome Measures (PROMs) Conference Birmingham 2018

Kathy, Mogens, Collette, 2018, Journal of Patient-Reported Outcomes.

Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials

L. Collette, M. Piccart, M. Taphoorn, 2018, Clinical trials.

Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?

Juan Manuel Ramos-Goñi, Oliver Rivero-Arias, Koonal K. Shah, 2021, Medical decision making : an international journal of the Society for Medical Decision Making.

What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the development of the EQ-HWB?

J. C. Rejon-Parrilla, J. Connell, J. Brazier, 2021, The European Journal of Health Economics.

Truly inefficient or providing better quality of care? Analysing the relationship between risk-adjusted hospital costs and patients' health outcomes.

A. Street, N. Devlin, N. Gutacker, 2011, Health economics.

Multi-Criteria Decision Analysis (MCDA) in Healthcare Decision-Making

P. Hansen, N. Devlin, 2019, Oxford Research Encyclopedia of Economics and Finance.

Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments

N. Devlin, N. Luo, Fan Yang, 2018, The European Journal of Health Economics.

Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?

N. Devlin, N. Luo, Fan Yang, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia

M. Herdman, N. Devlin, M. Pavesi, 2017, Quality of Life Research.

Lead versus lag-time trade-off variants: does it make any difference?

Mark Oppe, Federico Augustovski, V. Irazola, 2013, The European Journal of Health Economics.

Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L

R. Norman, N. Devlin, O. Rivero-Arias, 2022, PharmacoEconomics.

EQ-5D-5L Health-State Values for the Mexican Population

N. Devlin, B. Zamora, K. Shah, 2021, Applied Health Economics and Health Policy.

One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands

Mark Oppe, Andrew Lloyd, Koonal K. Shah, 2013, The European Journal of Health Economics.

Protocols for Time Tradeoff Valuations of Health States Worse than Dead: A Literature Review

A. Tsuchiya, N. Devlin, K. Buckingham, 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)

Martina Garau, Nancy Devlin, Grace Hampson, 2017, PharmacoEconomics - Open.

Opportunity costs and local health service spending decisions: a qualitative study from Wales

D. Hughes, N. Devlin, J. Sussex, 2016, BMC Health Services Research.

Local health care expenditure plans and their opportunity costs.

Jon Sussex, Nancy Devlin, N. Devlin, 2015, Health policy.

Opportunity Costs of Implementing Nice Decisions in NHS Wales.

N. Devlin, J. Sussex, D. Hughes, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

"Yes", "No" or "Yes, but"? Multinomial modelling of NICE decision-making.

Nancy J Devlin, N. Devlin, H. Dakin, 2006, Health policy.

The validity and reliability of EQ-5D health state valuations in a survey of Māori

P. Hansen, N. Devlin, M.R.V. Perkins, 2004, Quality of Life Research.

Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia.

Julie A. Campbell, P. Clarke, N. Devlin, 2021, Health economics.

"New Age" Decision Making in HTA: Is It Applicable in Asia?

N. Devlin, W. Oortwijn, G. Marsden, 2016 .

Variations in Patients’ Overall Assessment of Their Health Across and Within Disease Groups Using the EQ-5D Questionnaire: Protocol for a Longitudinal Study in the Swedish National Quality Registers

N. Devlin, D. Parkin, O. Rolfson, 2021, JMIR research protocols.

Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L

M. Herdman, N. Devlin, C. Kerr, 2020, Journal of Patient-Reported Outcomes.

Hypothetical versus experienced health state valuation: a qualitative study of adult general public views and preferences

J. Brazier, N. Devlin, D. Rowen, 2022, Quality of Life Research.

Psychometric Performance of HRQoL Measures: An Australian Paediatric Multi-Instrument Comparison Study Protocol (P-MIC)

H. Hiscock, N. Devlin, B. Mulhern, 2021, Children.

A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach.

Aki Tsuchiya, A. Tsuchiya, N. Devlin, 2011, Health economics.

The EQ-5D-5L Value Set for England: Response to the "Quality Assurance".

Brendan Mulhern, Yan Feng, Ben van Hout, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Distribution of the EQ-5D-5L Profiles and Values in Three Patient Groups.

N. Devlin, B. Zamora, A. Bateman, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The Online Elicitation of Personal Utility Functions (OPUF) tool: a new method for valuing health states

J. Brazier, N. Devlin, B. van Hout, 2022, Wellcome open research.

Novel Approaches to Value Assessment Within the Cost-Effectiveness Framework.

L. Garrison, J. Jansen, N. Devlin, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Understanding health state valuations: A qualitative analysis of respondents' comments

Paul Hansen, Caroline Selai, P. Hansen, 2004, Quality of Life Research.

Allocating Vote: Health — ‘Needs Assessment’ and an Economics-Based Approach

P. Hansen, N. Devlin, 2000 .

What is the Normative Basis for Selecting the Measure of 'Average' Preferences for Use in Social Choices?

Koonal Shah, Nancy Devlin, N. Devlin, 2017 .

Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L

Koonal Shah, Nancy Devlin, Juan Manuel Ramos Goni, 2018, PharmacoEconomics.

Technical efficiency in the New Zealand dairy industry: a frontier production function approach

Nancy Devlin, Mohammad Jaforullah, N. Devlin, 1996 .

A note on the relationship between age and health-related quality of life assessment

Koonal Shah, Patricia Cubi-Molla, Nancy Devlin, 2018, Quality of Life Research.

Guidance to users of EQ-5D value sets

Nancy Devlin, David Parkin, N. Devlin, 2007 .

Analysis of EQ-5D Profiles

David Parkin, Nancy Devlin, Bas Janssen, 2020, Methods for Analysing and Reporting EQ-5D Data.

A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.

N. Devlin, F. D. de Charro, B. van Hout, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates

Koonal Shah, Iain Blair, Nancy Devlin, 2015 .

A New Valuation Method: Directly Eliciting Personal Utility Functions

N. Devlin, B. Mulhern, K. Shah, 2017 .

University of Birmingham Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials

L. Collette, M. Piccart, M. Taphoorn, 2018 .

A ‘new and improved’ EQ-5D valuation questionnaire?

P. Hansen, N. Devlin, P. Herbison, 2005, The European Journal of Health Economics.

Preparatory study for the revaluation of the EQ-5D tariff: methodology report.

J. Cairns, J. Brazier, A. Tsuchiya, 2014, Health technology assessment.

The Influence of Cost-Effectiveness and Other Factors on NICE Decisions

N. Devlin, N. Rice, D. Parkin, 2013, Health economics.